Smad4 is Associated With Differentiation of Pancreatic Ductal Adenocarcinomas

被引：0
|
作者：
Izumi, S. [1 ]
Ichihara, S. [1 ]
Kubo, T. [1 ]
Ohtani, H. [1 ]
Yano, M. [1 ]
Tanaka, N. [1 ]
Ohashi, R. [1 ]
Onoda, Y. [1 ]
Suzuka, I. [1 ]
机构：
[1] Kagawa Prefectural Cent Hosp, Dept Surg Gastroenterol, Takamatsu, Kagawa, Japan
来源：
PANCREAS | 2014年 / 43卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1369 / 1369
页数：1
相关论文
共 50 条
  • [41] SMAD4 and its role in pancreatic cancer
    Xia, Xiang
    Wu, Weidong
    Huang, Chen
    Cen, Gang
    Jiang, Tao
    Cao, Jun
    Huang, Kejian
    Qiu, Zhengjun
    TUMOR BIOLOGY, 2015, 36 (01) : 111 - 119
  • [42] The Role of SMAD4 Inactivation in Epithelial-Mesenchymal Plasticity of Pancreatic Ductal Adenocarcinoma: The Missing Link?
    Racu, Marie-Lucie
    Lebrun, Laetitia
    Schiavo, Andrea Alex
    Van Campenhout, Claude
    De Clercq, Sarah
    Absil, Lara
    Minguijon Perez, Esmeralda
    Maris, Calliope
    Decaestecker, Christine
    Salmon, Isabelle
    D'Haene, Nicky
    CANCERS, 2022, 14 (04)
  • [43] SMAD4 expression in breast ductal carcinoma correlates with prognosis
    Liu, Nannan
    Yu, Chunyan
    Shi, Yanfen
    Jiang, Jing
    Liu, Yuhe
    ONCOLOGY LETTERS, 2015, 10 (03) : 1709 - 1715
  • [44] Combination immunohistochemistry for SMAD4 and Runt-related transcription factor 3 (RUNX3) may identify a favourable prognostic subgroup of pancreatic ductal adenocarcinomas
    Lee, Y. -K.
    Lee, H. -J.
    Park, H. -J.
    Kim, J. -W.
    Hwang, J. -H.
    Kim, J. -H.
    Yoon, Y. -S.
    Han, H. -S.
    Lee, K. -S.
    Shin, E.
    Kim, H. -Y.
    VIRCHOWS ARCHIV, 2016, 469 : S86 - S86
  • [45] Combination Immunohistochemistry for SMAD4 and Runt-Related Transcription Factor 3 (RUNX3) May Identify a Favorable Prognostic Subgroup of Pancreatic Ductal Adenocarcinomas
    Lee, Yangkyu
    Lee, Hyejung
    Park, Hyunjin
    Kim, Jin-Won
    Hwang, Jin-Hyeok
    Kim, Jaihwan
    Yoon, Yoo-Seok
    Han, Ho-Seong
    Kim, Haoyoung
    MODERN PATHOLOGY, 2017, 30 : 446A - 446A
  • [46] SMAD4 gene mutation and prognosis of pancreatic adenocarcinoma
    Derbel, Olfa
    de la Fouchardiere, Arnaud
    Peron, Julien
    Desseigne, Francoise
    Heudel, Pierre
    Guibert, Pierre
    Rivoire, Michel
    Meeus, Pierre
    Peyrat, Patrice
    Lemaistre, Anne-Isabelle
    De La Fouchardiere, Christelle
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [47] Combination Immunohistochemistry for SMAD4 and Runt-Related Transcription Factor 3 (RUNX3) May Identify a Favorable Prognostic Subgroup of Pancreatic Ductal Adenocarcinomas
    Lee, Yangkyu
    Lee, Hyejung
    Park, Hyunjin
    Kim, Jin-Won
    Hwang, Jin-Hyeok
    Kim, Jaihwan
    Yoon, Yoo-Seok
    Han, Ho-Seong
    Kim, Haeryoung
    LABORATORY INVESTIGATION, 2017, 97 : 446A - 446A
  • [48] Prognostic value of SMAD4 in resectable pancreatic cancer
    Su, Hui
    Wang, Cunchuan
    POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2022, 76 (01): : 324 - 332
  • [49] The effect of SMAD4 expression on angiogenesis of pancreatic adenocarcinoma
    Schrödel, A.
    Jesnowski, R.
    Molema, I.
    Löhr, M.
    JOURNAL OF VASCULAR RESEARCH, 2006, 43 : 74 - 74
  • [50] Claudia 4 is overexpressed in invasive pancreatic ductal adenocarcinomas
    Nichols, LS
    Ashfaq, R
    Hruban, RH
    Iacobuzio-Donahue, CA
    LABORATORY INVESTIGATION, 2003, 83 (01) : 283A - 283A
12345